OPHTHALMOPHARMA AG – Trademark Portfolio

Entity Type: 98

OPHTHALMOPHARMA AG holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 5 Nice Classification classes.

c/o Gabriel & Müller

Bahnhofplatz 5 CH-6060 Sarnen

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

OPHTHALMOPHARMA AG's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does OPHTHALMOPHARMA AG have?

OPHTHALMOPHARMA AG has 4 U.S. trademarks filed with the USPTO.

What trademark classes does OPHTHALMOPHARMA AG file in?

OPHTHALMOPHARMA AG files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 42 covers scientific and technological services; industrial analysis and research services.

What is OPHTHALMOPHARMA AG's trademark registration success rate?

OPHTHALMOPHARMA AG has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.